Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Total Assets (Quarterly): 159.45M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 159.45M |
| June 30, 2024 | 158.89M |
| March 31, 2024 | 122.05M |
| December 31, 2023 | 137.24M |
| September 30, 2023 | 142.48M |
| June 30, 2023 | 154.76M |
| March 31, 2023 | 164.61M |
| December 31, 2022 | 156.65M |
| Date | Value |
|---|---|
| September 30, 2022 | 161.26M |
| June 30, 2022 | 174.32M |
| March 31, 2022 | 185.25M |
| December 31, 2021 | 193.42M |
| June 30, 2021 | 129.01M |
| March 31, 2021 | 129.71M |
| June 30, 2020 | 42.93M |
| December 31, 2019 | 17.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.02M
Minimum
Dec 2019
193.42M
Maximum
Dec 2021
139.32M
Average
155.71M
Median
Total Assets (Quarterly) Benchmarks
| Galapagos NV | 4.660B |
| UCB SA | 16.75B |
| Mithra Pharmaceuticals SA | 407.25M |
| Celyad Oncology SA | 13.23M |
| MDxHealth SA | 157.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.51M |
| Shareholders Equity (Quarterly) | 116.95M |
| Debt to Equity Ratio | 0.1866 |
| Current Ratio | 5.283 |
| Net Debt Paydown Yield | -0.73% |